JUSRX
Price
$23.81
Change
-$0.01 (-0.04%)
Updated
May 9 closing price
Net Assets
30.11B
VTSMX
Price
$135.29
Change
-$0.08 (-0.06%)
Updated
May 9 closing price
Net Assets
1.72T
Ad is loading...

JUSRX vs VTSMX

Header iconJUSRX vs VTSMX Comparison
Open Charts JUSRX vs VTSMXBanner chart's image
JPMorgan US Equity R5
Price$23.81
Change-$0.01 (-0.04%)
VolumeN/A
Net Assets30.11B
Vanguard Total Stock Mkt Idx I
Price$135.29
Change-$0.08 (-0.06%)
VolumeN/A
Net Assets1.72T
JUSRX vs VTSMX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JUSRX vs. VTSMX commentary
May 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JUSRX is a Buy and VTSMX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VTSMX has more cash in the bank: 1.72T vs. JUSRX (30.1B). VTSMX pays higher dividends than JUSRX: VTSMX (1.26) vs JUSRX (0.65). JUSRX was incepted earlier than VTSMX: JUSRX (19 years) vs VTSMX (33 years). JUSRX (0.57) is less costly to investors than VTSMX (0.14). JUSRX is a more actively managed with annual turnover of: 53.00 vs. VTSMX (2.00). JUSRX has a lower initial minimum investment than VTSMX: JUSRX (0) vs VTSMX (3000). VTSMX annual gain was more profitable for investors over the last year : 8.01 vs. JUSRX (1.54). VTSMX return over 5 years is better than : 89.29 vs. JUSRX (59.06).
JUSRXVTSMXJUSRX / VTSMX
Total Expense Ratio0.540.14386%
Annual Report Gross Expense Ratio0.570.14407%
Fund Existence19 years33 years-
Gain YTD-4.318-3.965109%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets30.1B1.72T2%
Annual Yield % from dividends0.651.2652%
Returns for 1 year1.548.0119%
Returns for 3 years30.7940.1577%
Returns for 5 years59.0689.2966%
Returns for 10 years71.46165.4043%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UPC4.880.10
+2.09%
Universe Pharmaceuticals Inc
BG77.351.08
+1.42%
Bunge Global SA
EVBN39.53N/A
N/A
Evans Bancorp
OFLX30.83N/A
N/A
Omega Flex
HTGC17.48-0.11
-0.63%
Hercules Capital